News

March 12, 2025

RAYMOND J. O’ROURKE, CRISIS AND REPUTATION MANAGEMENT EXPERT, JOINS THE COMMUNICATIONS STRATEGY GROUP AS A SENIOR ADVISOR.

Former senior executive with Morgan Stanley, Burson-Marsteller and Nataxis Global Asset Management Boston, MA, March 12, 2025—The Communications Strategy Group Inc., a Boston-based corporate/financial communications […]
Do you like it?0
Read more
December 13, 2024

JOHN MACLENNAN, PHD, FORMER BRITISH DIPLOMAT, JOINS COMMUNICATIONS STRATEGY GROUP AS SENIOR CONSULTANT

Most recently Vice Consul, US Biotech Sector Lead for Trade and Investment, British Consulate-General, Boston Brings deep experience in helping overseas companies connect with US […]
Do you like it?0
Read more
November 5, 2024

KITHER BIOTECH ANNOUNCES PHASE 1 CLINICAL STUDY OF KIT2014, A NOVEL INHALED PEPTIDE THERAPY FOR CYSTIC FIBROSIS

• Study to evaluate the safety and tolerability of KIT2014, an inhaled peptide therapy designed to enhance Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) function, act […]
Do you like it?0
Read more
October 24, 2024

Ikarovec’s seed round extension brings total to £8M with proceeds to advance lead sight loss programme towards clinic

Funds raised to continue advanced pre-clinical trials of novel gene therapies to treat blindness and major chronic eye disease Led by LifeArc Ventures and Parkwalk […]
Do you like it?0
Read more
12345678910
Next page